Home-Based Exercise Gaming for Physically Inactive Individuals
Launched by INSEL GRUPPE AG, UNIVERSITY HOSPITAL BERN · Nov 17, 2020
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
Current guidelines recommend that adults undertake at least 150 minutes of moderate intensity physical activity or 75 minutes of vigorous physical activity per week. Regular physical activity improves many cardiovascular and metabolic health makers including beneficial effects on body weight, insulin sensitivity, glycaemic control, lipid profile, endothelial function and aerobic capacity. Despite overwhelming evidence that an inactive lifestyle leads to chronic disease and premature death, many adults fail to meet physical activity guidelines. Physical inactivity, defined as physical activi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female
- • Aged 18-55
- • Physically inactive, defined as not meeting the exercise guidelines of 150 minutes of moderate physical activity or 75 minutes of vigorous physical activity per week
- • BMI 18.5 kg/m2 - 30 kg/m2
- • No known cardiovascular disorders
- • Able to provide written informed consent and understand instructions
- Exclusion Criteria:
- • Overt diabetes mellitus (type 1, type 2, other forms of diabetes)
- • Pregnant, planning on becoming pregnant during the study, or breast feeding
- • Physical or psychological disease likely to interfere with the normal conduct of the study as judged by the investigator
About Insel Gruppe Ag, University Hospital Bern
Insel Gruppe AG, the umbrella organization for the University Hospital Bern, is a leading healthcare provider in Switzerland, renowned for its commitment to advancing medical research and patient care. As a key player in clinical trials, Insel Gruppe AG integrates cutting-edge scientific inquiry with clinical excellence, facilitating innovative studies that span a wide range of medical disciplines. The institution prioritizes collaboration with academic partners and industry stakeholders to enhance the understanding of diseases and develop effective treatment options, ultimately aiming to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bern, , Switzerland
Patients applied
Trial Officials
Christoph Stettler, MD
Principal Investigator
University of Bern
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials